Australia second in the world for methylamphetamine use

Australia second in the world for methylamphetamine use
Credit: JamesRonin from Pixabay

The Australian Criminal Intelligence Commission (ACIC) today released the 14th report of its National Wastewater Drug Monitoring Program (the Program). This report presents data on Australia's drug consumption for 12 substances. The April 2021 collection covered around 56 percent of Australia's population—about 13 million Australians.

This reporting period again demonstrated varying trends in , both nationally and within our states and territories. Of the drugs measured by the Program with available dose data, alcohol and nicotine remain the most consumed drugs in Australia, with methylamphetamine the most consumed . This report showed signs of recovery in the methylamphetamine market, which remains Australia's highest risk market by some margin.

ACIC CEO Mr Michael Phelan APM said that the methylamphetamine market is a very resilient market because is widespread and strong in both the capital cities and regional locations. Methylamphetamine is a wicked problem because serious organized crime (SOC) groups both import the finished product and precursor chemicals and domestically manufacture methylamphetamine. Wastewater analysis provides a timely indication of both the extent of supply by serious and organized crime (SOC) groups and also locations where they have a footprint. Sadly, the report shows that SOC groups will always find a way to supply illicit drug markets, Mr Phelan said.

Other findings this reporting period are that fentanyl and oxycodone consumption decreased to the lowest levels recorded by the Program, heroin consumption continued to decline and cocaine also decreased. In April 2021, capital city MDMA consumption exceeded regional consumption for the first time since August 2017 but average consumption of this drug has decreased from record highs in December 2019. This pre-dated the COVID period, so we believe that the decrease is due to a combination of decreasing imports to Australia by SOC groups and the impact of COVID-19 restrictions, which saw entertainment venues closed and festivals canceled. Heroin, cocaine and MDMA are wholly or largely supplied via importations by SOC groups so decreases in consumption are due to a combination of supply-side interventions and temporary reductions in consumption.

"There is no doubt that wastewater analysis is important to everyday Australians and benefits them directly," Mr Phelan said. The Program means that response agencies, stakeholders and interested members of the community can develop an informed understanding of trends in drug consumption and allows the progress of demand, supply and harm reduction strategies to be monitored.

"The ACIC and the Australian Government recognizes the valuable contribution of wastewater analysis to informing decision making on a range of drug and public health issues," he said.

"The Program's data continue to demonstrate the challenges facing different cities and towns and also unique characteristics of local drug markets, forming a meaningful part of bespoke solutions for each region."

The data, when merged with other data including from the ACIC's Illicit Drug Data Report and our intelligence holdings, also permits the ACIC to analyze the ability of transnational and domestic serious organized crime groups to adapt to different market circumstances.

"Much of the harm that Australians suffer at the hands of organized crime is due to illicit drugs. Serious and organized crime groups profit from the importation, manufacture, trafficking and sale of drugs that cause harm to the community.

"Law enforcement agencies can commence some investigations in the knowledge that the impact on local drug consumption can be measured by wastewater analysis, government and health agencies can effectively allocate resources to priority areas, and the public can be informed of the level of harm caused," said Mr Phelan.

The report also provides updated 2020 data from the Sewage Core Group Europe (SCORE), which extends to Europe, North America, South Africa and Oceania. Australia had the second highest methylamphetamine consumption of 24 countries. Of the 26 countries reporting cocaine and MDMA consumption, Australia ranked 16th and seventh respectively. For the first time, cannabis has been included in the drugs monitored as part of the SCORE analysis. Of the 16 countries in which cannabis was monitored, Australia ranked seventh.

"The results confirm the strong preference in world terms by Australian illicit drug users for illicit stimulants (in particular methylamphetamine, MDMA and cocaine) and the domination of our domestic stimulant market by methylamphetamine," Mr Phelan said.


Explore further

Wastewater drug monitoring program provides insight into Australia's drug consumption

More information: The report is available online: www.acic.gov.au
Provided by Australian Criminal Intelligence Commission
Citation: Australia second in the world for methylamphetamine use (2021, October 28) retrieved 23 January 2022 from https://medicalxpress.com/news/2021-10-australia-world-methylamphetamine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors